diabetes

Novo Nordisk's weekly diabetes drug goes 5-for-5 in Phase III
Fierce Biotech
Thu, 02/25/16 - 09:58 am
diabetes
Novo Nordisk
semaglutide
Sanofi tried and failed with Afrezza. Why does MannKind still think it can win?
Fierce Pharma
Wed, 02/10/16 - 09:55 pm
Sanofi
Afrezza
MannKind
diabetes
How Novo’s Diabetes and Obesity Care Segment Performed in 4Q15
Yahoo/Market Realist
Mon, 02/8/16 - 09:29 pm
Novo Nordisk
obesity
diabetes
earnings
Insulin wars heat up as Novo's Tresiba bests Lantus in major safety outcomes trial
BioPharma Dive
Thu, 02/4/16 - 09:27 am
Novo Nordisk
insulin
diabetes
Tresiba
Lantus
Sanofi
Express Scripts ditches Valeant diabetes med as part of 2016 formulary shakeup
BioPharma Dive
Mon, 02/1/16 - 11:50 am
Express Scripts
Valeant Pharmaceuticals
diabetes
Glumetza
Eli Lilly's diabetes drugs drive sales
Medical Marketing and Media
Sat, 01/30/16 - 10:40 am
Eli Lilly
diabetes
earnings
Express Scripts Blocks Valeant Diabetes Drug in Cost Fight
Bloomberg
Fri, 01/29/16 - 10:37 am
Express Scripts
Valeant Pharmaceuticals
drug pricing
diabetes
Glumetza
Johnson & Johnson's Newest Billion-Dollar Blockbuster
Motley Fool
Thu, 01/28/16 - 08:58 am
JNJ
diabetes
Invokana
Lilly, BI step closer to a new heart-risk marketing push on Jardiance
Fierce Pharma Marketing
Wed, 01/27/16 - 04:12 pm
Eli Lilly
Boehringer Ingelheim
diabetes
Jardiance
SGLT2 inhibitor
Marketing challenges remain in crowded metabolic market
Medical Marketing and Media
Tue, 01/26/16 - 09:16 pm
diabetes
Eli Lilly
Sanofi
Novo Nordisk
obesity
Novo Nordisk rolls out long-awaited Tresiba, aiming for blockbuster market share
Fierce Pharma
Tue, 01/26/16 - 12:36 pm
Novo Nordisk
Tresiba
diabetes
MannKind Launches New Direction For Afrezza
Seeking Alpha
Fri, 01/22/16 - 09:06 am
MannKind
Afrezza
diabetes
Sanofi
How Is Novo Nordisk’s Position in the Diabetes Segment?
Yahoo/Market Realist
Mon, 01/18/16 - 08:22 pm
Novo Nordisk
diabetes
Theracos raises $25M to take on Big Pharma in diabetes
Fierce Biotech
Sat, 01/16/16 - 11:39 am
Theracos
diabetes
SGLT2 inhibitor
China’s diabetes boom promises $23 billion pot for drug makers
Marketwatch
Fri, 01/15/16 - 02:30 pm
China
diabetes
Novo Nordisk
Sanofi
Eli Lilly
Zhejiang Hisun Pharma
The Lesson Of MannKind Corporation
Seeking Alpha
Thu, 01/7/16 - 08:56 am
MannKind
Sanofi
Afrezza
diabetes
inhaled insulin
MannKind Corp. Sinks Again On Bankruptcy Concerns
Motley Fool
Wed, 01/6/16 - 10:47 am
MannKind
bankruptcy
Afrezza
Sanofi
inhaled insulin
diabetes
2 Reasons Behind MannKind Corporation's Implosion in 2015
Motley Fool
Tue, 01/5/16 - 09:17 pm
MannKind
Afrezza
diabetes
Sanofi
Eli Lilly's diabetes pill takes market share from J&J, Astra
Yahoo/Reuters
Tue, 01/5/16 - 09:16 pm
Eli Lilly
JNJ
AstraZeneca
diabetes
Jardiance
Panasonic closes $1B Bayer diabetes biz buy
Mass Device
Tue, 01/5/16 - 09:14 pm
Panasonic
Bayer
diabetes
devices
blood glucose monitoring

Pages